Clinical Trial Update: Effectiveness of Protected Environment Rooms for AML and MDS

View source ↗

Summary

Clinical trial update on the effectiveness of protected environment rooms for Acute Myeloid Leukemia and Myelodysplastic Syndrome; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Status: TERMINATED